Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Regulatory News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

Share Price is delayed by 15 minutes
Get Live Data
1,471.00    11.00 (0.75%)
Bid:
1,475.00
Ask:
1,477.00
Spread: 2.00 (0.136%)
Market Cap: £3.13b
HIK Live PriceLast checked at - London Stock Exchange

Intraday Hikma Pharmaceuticals Share Chart

Option Exercise

19 Sep 2007 16:22

Hikma Pharmaceuticals Plc19 September 2007 For Immediate Release 19 September 2007 Hikma Pharmaceuticals PLC (the "Company") Director/PDMR Shareholding Notification of Option Exercise On 19 September 2007 the following PDMRs exercised their option to purchase thenumber of ordinary shares of 10 pence each set out in the table below in thecapital of the Company. These options were granted on the dates shown belowpursuant to the Company's 2004 Stock Option Plan: +--------------------+---------------+-------------------------------------+|Name |Date of Grant |Number of Shares Exercised |+--------------------+---------------+-------------------------------------+|Majda Labadi |12 October 2004|120,000 |+--------------------+---------------+-------------------------------------+|Taghreed Al Shunnar |12 October 2004|120,000 |+--------------------+---------------+-------------------------------------+ On 19 September 2007, the PDMRs disposed of the following number of shares acquired pursuant to the exercise of the options set out above: +-------------------+-----------------+------------------------+-------------------------+---------------------------+|Name |Date of Disposal |Market Price on Disposal|Number of Shares Disposed|Percentage of Share capital|| | | | | |+-------------------+-----------------+------------------------+-------------------------+---------------------------+|Majda Labadi |19 September 2007|£4.210201 |120,000 |0.0708% |+-------------------+-----------------+------------------------+-------------------------+---------------------------+|Taghreed Al Shunnar|19 September 2007|£4.210201 |120,000 |0.0708% |+-------------------+-----------------+------------------------+-------------------------+---------------------------+ As a result of the above transactions the Executive Directors and PDMRs listedbelow now have the following holdings in the ordinary share capital of theCompany: +-------------------+------------------------------+---------------------------+|Name |Ordinary Shares in the Company|Percentage of Share capital|| | | |+-------------------+------------------------------+---------------------------+|Majda Labadi |305,740 |0.1804% |+-------------------+------------------------------+---------------------------+|Taghreed Al Shunnar|29,640 |0.0175% |+-------------------+------------------------------+---------------------------+ The issued share capital of Hikma Pharmaceuticals PLC is now 169,435,407 ordinary shares of 10 pence each. Date of Notification: 19 September 2007 Henry KnowlesCompany Secretary020 7399 2760 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Aug 20177:00 amRNSHalf-year Report
10th Aug 201710:05 amRNSDirector/PDMR Shareholding
10th Aug 201710:02 amRNSDirector/PDMR Shareholding
9th Aug 20179:54 amRNSDirector/PDMR Shareholding
4th Aug 20179:56 amRNSHolding(s) in Company
3rd Aug 20172:22 pmRNSNotice of Results
24th Jul 201710:53 amRNSHolding(s) in Company
4th Jul 201711:02 amRNSTotal Voting Rights
3rd Jul 20173:03 pmRNSHolding(s) in Company
30th Jun 20174:11 pmRNSHolding(s) in Company
26th Jun 20177:00 amRNSLeadership and Structural Changes to US Business
12th Jun 20174:31 pmRNSDirector/PDMR Shareholding
2nd Jun 20174:51 pmRNSTotal Voting Rights
31st May 20179:38 amRNSDirector/PDMR Shareholding
19th May 20172:44 pmRNSResult of AGM
19th May 20177:00 amRNSTrading Statement
15th May 20173:30 pmRNSDirector/PDMR Shareholding
11th May 20177:50 amRNSHikma update on ANDA for generic Advair Diskus
8th May 20179:23 amRNSChange of Registered Address
3rd May 20175:23 pmRNSTotal Voting Rights
3rd May 201710:37 amRNSChange of Registered Office
28th Apr 20172:30 pmRNSDirector/PDMR Shareholding
28th Apr 20171:57 pmRNSDirector/PDMR Shareholding
24th Apr 20173:35 pmRNSDirector/PDMR Shareholding
13th Apr 20178:58 amRNSDirector/PDMR Shareholding
13th Apr 20178:43 amRNSDirector/PDMR Shareholding
13th Apr 20178:42 amRNSDirector/PDMR Shareholding
13th Apr 20178:41 amRNSDirector/PDMR Shareholding
13th Apr 20178:36 amRNSDirector/PDMR Shareholding
11th Apr 20174:01 pmRNSDirector/PDMR Shareholding
7th Apr 201711:55 amRNSAnnual Financial Report
6th Apr 20177:00 amRNSHikma enters into settlement agreement with Jazz
3rd Apr 20173:59 pmRNSTotal Voting Rights
3rd Apr 20173:56 pmRNSBlock listing Interim Review
27th Mar 201711:13 amRNSHolding(s) in Company
23rd Mar 20179:30 amRNSDirector/PDMR Shareholding
15th Mar 20177:00 amRNSFinal Results
10th Mar 20177:30 amRNSHikma launches Desvenlafaxine Succinate Tablets
8th Mar 20174:01 pmRNSNotice of Results
8th Mar 20171:30 pmRNSDirector/PDMR Shareholding
1st Mar 20172:38 pmRNSTotal Voting Rights
13th Feb 20179:19 amRNSLicensing agreement with Orion for Easyhaler®
6th Feb 20172:27 pmRNSTotal Voting Rights
6th Feb 201712:47 pmRNSHolding(s) in Company
18th Jan 20179:11 amRNSHikma receives approval for Sodium Oxybate
20th Dec 20163:24 pmRNSDirector/PDMR Shareholding
20th Dec 201611:00 amRNSHolding(s) in Company
20th Dec 201610:47 amRNSDirector/PDMR Shareholding
13th Dec 20161:46 pmRNSDirector/PDMR Shareholding
12th Dec 20164:06 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.